3D Cell Culture Market By Product (Scaffold Based Platforms, Scaffold Free Platforms, Gels, Bioreactors, Microchips, Services), By Application (Cancer Research, Stem Cell Research, Drug Discovery, Regenerative medicine), By End User (Biotechnology and Pharmaceutical Companies, Contract Research Laboratories, Academic Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2031

3D Cell Culture Market

A 3D cell culture is defined as an assembly of biological cells in in-vitro environment in a particular pattern that resembles the in-vivo conditions present inside the human body. 3D cell cultures are mainly categorized into three types namely, standard cultures, organ-on-chip models, and tissue bioengineering. The use of 3D cell culture technology is recognized as an essential tool in drug discovery, toxicology testing, tissue engineering, and basic research. Cell culturing in 3D allows the expression of extracellular matrix (ECM) components and enhanced interactions with the culture environment.

These characteristics play an important role in replicating in-vivo processes such as cell adherence, differentiation and proliferation in in-vitro conditions. The implementation of these approaches for developing predictive in-vitro screening assays resembling physiological environment for preclinical drug development is facilitating the use of 3D cell cultures in research.

The global 3D cell culture market size has witnessed exponential growth in the past few years due to shift in preferences of the researchers toward the use of these cultures, especially in cancer research. The cells in these cultures grow three dimensionally with zones of oxygen & nutrient gradients and cellular heterogeneity that closely reflects in-vivo microenvironment. As a result, several cellular functional differences such as alterations in protein expressions and responsiveness to inhibitor molecules are observed when cells are grown in 3D cell cultures in comparison to 2D.

Thus, these cultures provide a competitive edge over the monolayer cultured cells notably in drug discovery and development. Therefore, these factors are expected to impel the growth of the market during the forecast period. Moreover, global rise in the demand for organ transplantation owing to prevalence in lifestyle and chronic diseases is predicted to supplement the market growth further. On the contrary, costs associated with implantation of 3D cell cultures in contrast to 2D and irregularity in outcomes due to lack of standardized protocols are anticipated to restrict the growth of the market.

However, the emergence of advanced and innovative 3D cell culture technologies in coming years is expected to fuel the market growth. Furthermore, the impact of COVID-19 pandemic is expected to remain moderate for pharmaceutical and biotechnological companies in the 3D cell culture industry. The prominent players in the market are facing a set-back, due to the lockdowns, which has led to a drop in the manufacturing and use of 3D cell culture among the researchers across universities & academic institutes. However, this deleterious impact is being compensated by a rapid development in stem cell therapy research and increase in R&D for developing regenerative medicines for treating COVID-19 patients.

The 3D cell culture market size is segmented on the basis of product, application, end user, and region. By product, the market is classified into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. The scaffold-based platforms segment dominated the 3D cell culture market share in 2021, and is estimated to register a CAGR of 18.8% from 2022-2031. 

By application, the 3D cell culture market is divided into cancer research, stem cell research, drug discovery, and regenerative medicine. The cancer research segment dominated the global 3D cell culture market trends in 2021, and is estimated to register a CAGR of 17.3% from 2022 to 2031.

By end user, the market is categorized into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment dominated the 3D cell culture market analysis in 2021, and is expected to grow with a significant growth rate of 18.45% from 2022 to 2031.

Region wise, the market has been analyzed across four regions namely, North America, Europe, Asia-Pacific, and LAMEA. The North America 3D cell culture market accounted for a major share of the global market registering an estimated CAGR of 16.3% during the forecast period. The growth trend in the North America market is characterized by the maturity of the market, in terms of penetration and availability of advanced 3D cell culture products.

 

Key findings of the study

•    By product, microchips segment is expected to grow at the highest CAGR of 21.3% during the forecast period.

•    By end user, the academic institutes segment accounted for nearly half of the share of the global 3D Cell Culture industry in 2020.

•    Region-wise, Asia Pacific is expected to experience growth at the highest rate, registering a CAGR of 19.8% during the 3D cell culture market forecast period.

Overview

A 3D cell culture is an in-vitro technique wherein the cells can grow in an artificially created environment. These environments closely resemble the architecture and functioning of the native tissue. 3D cell culture technique helps stimulate cell differentiation, proliferation, and migration by interacting with their three-dimensional surroundings as they would in the in-vivo environment. As 3D cell cultures can mimic the structure, activity, and microenvironment of the in-vivo tissues, this technique has varied applications in the fields of drug screening, regenerative medicine, stem cell therapies, cancer research and cell biology. The extracellular matrix in 3D cell cultures enables cell–cell communication by direct contact as in in-vivo environment by secreting cytokines and trophic factors. These factors are changed in a 2D environment that can significantly affect the cell–cell communication, which in turn can alter the cell morphology and proliferation. As 2D cultures cannot recapitulate the architecture and complex cellular matrices as in 3D cultures, this technique is gaining popularity in healthcare research sector. In addition, 3D cell cultures can provide results with improved efficiency and reduce the cost of overall R&D process. 

Based on product, the 3D cell culture market can be categorized into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are used to alter the cell culture procedure by providing a surface on which the cells can easily impart 3D growth. Scaffolds are used in drug discovery and cell expansion, owing to the availability of a variety of materials and structural choices. In addition, there are other advantages related to the use of scaffold-based platforms such as ease of imaging and simple assay protocol. Moreover, the mechanical and biochemical properties of the scaffold can easily be modified as per the need of the application. Thus, this segment is expected to dominate the product segment throughout the forecast period as there is a high demand for scaffold-based platforms for creating 3D cell cultures. Nevertheless, scaffold-based platforms can adsorb test compounds, limit downstream endpoints for analysis, and introduce different biological substances, thereby obstructing the segment growth.

Based on application, the 3D cell culture market is segmented into cancer research, stem cell research, drug discovery, and regenerative medicine. Cancer research segment is anticipated to be the largest growing segment over the analysis period. This is majorly attributed to the advantages offered by 3D cell culture in cancer research, these include ease of altering cell proliferation and morphology, revealing realistic drug response, capturing phenotypic heterogeneity, allowing experimental manipulation in gene expression & cell behavior and representing the tumor microenvironment. Preclinical studies that utilize the benefits of 3D cell culture early on can critically improvise the understanding of cancer biology. These include elimination of poor drug candidates and identification of physiologically relevant targets that were previously inaccessible in 2D cultures. This can largely contribute toward the segment growth.

Based on end user, the global 3D cell culture market is segmented into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. The academic institutes segment held a dominant position in the end user segment throughout the analysis period. This growth is due to rise in collaborations between several companies with research institutes and clinical laboratories owing to the rise in demand of 3D cell cultures for various healthcare applications. For instance, Procter & Gamble (P&G) and Durham University based in the UK have collaborated for engineering 3D skin substitutes with the help of tissue-mimetic 2D platforms for studying the process of ageing in-vitro. In addition, many academic institutes have focused their R&D activities toward 3D culture models for developing novel approaches for treating different medical conditions. This surge in research activities across academic institutes and universities is predicted to propel the growth of the segment over the analysis period.

North America is expected to maintain its dominance during the forecast period due to the presence of several pharmaceutical and biotechnology companies that use 3D culture technology in collaboration with research institutes and clinical laboratories for developing regenerative medicines and drug discovery & development. Furthermore, rise in demand for organ transplantation and upsurge in R&D activities focused on technologically advanced solutions is predicted to fuel the adoption of 3D cell culture practices in the region. In addition, surge in incidences of cancer has led the government to increase the funding and grants for R&D in the field of cancer, which may have a positive impact on the 3D cell culture market growth. Moreover, the strategic expansion of biotechnological and pharmaceutical companies has led to launch of advanced products, which are expected to augment the market growth in coming years.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the 3d cell culture market analysis from 2021 to 2031 to identify the prevailing 3d cell culture market opportunities.

The market research is offered along with information related to key drivers, restraints, and opportunities.

Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.

In-depth analysis of the 3d cell culture market segmentation assists to determine the prevailing market opportunities.

Major countries in each region are mapped according to their revenue contribution to the global market.

Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.

The report includes the analysis of the regional as well as global 3d cell culture market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

○ Thermo Fisher Scientific Inc

Scope of 3D Cell Culture Market Report

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

2.1.Key findings of the study

2.2.CXO Perspective

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Top player positioning

3.5.Market dynamics

3.5.1.Drivers

3.5.2.Restraints

3.5.3.Opportunities

3.6.COVID-19 Impact Analysis on the market

4.1 Overview

4.1.1 Market size and forecast

4.2 Scaffold Based Platforms

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market analysis by country

4.2.4 Scaffold Based Platforms 3D Cell Culture Market by Macro-scale

4.2.5 Scaffold Based Platforms 3D Cell Culture Market by Micro-scale

4.2.6 Scaffold Based Platforms 3D Cell Culture Market by Nano-scale

4.2.7 Scaffold Based Platforms 3D Cell Culture Market by Solid Scaffolds

4.3 Scaffold Free Platforms

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market analysis by country

4.4 Gels

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market analysis by country

4.5 Bioreactors

4.5.1 Key market trends, growth factors and opportunities

4.5.2 Market size and forecast, by region

4.5.3 Market analysis by country

4.6 Microchips

4.6.1 Key market trends, growth factors and opportunities

4.6.2 Market size and forecast, by region

4.6.3 Market analysis by country

4.7 Services

4.7.1 Key market trends, growth factors and opportunities

4.7.2 Market size and forecast, by region

4.7.3 Market analysis by country

5.1 Overview

5.1.1 Market size and forecast

5.2 Cancer Research

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market analysis by country

5.3 Stem Cell Research

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market analysis by country

5.4 Drug Discovery

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market analysis by country

5.5 Regenerative medicine

5.5.1 Key market trends, growth factors and opportunities

5.5.2 Market size and forecast, by region

5.5.3 Market analysis by country

6.1 Overview

6.1.1 Market size and forecast

6.2 Biotechnology and Pharmaceutical Companies

6.2.1 Key market trends, growth factors and opportunities

6.2.2 Market size and forecast, by region

6.2.3 Market analysis by country

6.3 Contract Research Laboratories

6.3.1 Key market trends, growth factors and opportunities

6.3.2 Market size and forecast, by region

6.3.3 Market analysis by country

6.4 Academic Institutes

6.4.1 Key market trends, growth factors and opportunities

6.4.2 Market size and forecast, by region

6.4.3 Market analysis by country

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key trends and opportunities

7.2.2 North America Market size and forecast, by Product

7.2.3 North America Market size and forecast, by Application

7.2.4 North America Market size and forecast, by End User

7.2.5 North America Market size and forecast, by country

7.2.5.1 U.S.

7.2.5.1.1 Market size and forecast, by Product

7.2.5.1.2 Market size and forecast, by Application

7.2.5.1.3 Market size and forecast, by End User

7.2.5.2 Canada

7.2.5.2.1 Market size and forecast, by Product

7.2.5.2.2 Market size and forecast, by Application

7.2.5.2.3 Market size and forecast, by End User

7.2.5.3 Mexico

7.2.5.3.1 Market size and forecast, by Product

7.2.5.3.2 Market size and forecast, by Application

7.2.5.3.3 Market size and forecast, by End User

7.3 Europe

7.3.1 Key trends and opportunities

7.3.2 Europe Market size and forecast, by Product

7.3.3 Europe Market size and forecast, by Application

7.3.4 Europe Market size and forecast, by End User

7.3.5 Europe Market size and forecast, by country

7.3.5.1 Germany

7.3.5.1.1 Market size and forecast, by Product

7.3.5.1.2 Market size and forecast, by Application

7.3.5.1.3 Market size and forecast, by End User

7.3.5.2 France

7.3.5.2.1 Market size and forecast, by Product

7.3.5.2.2 Market size and forecast, by Application

7.3.5.2.3 Market size and forecast, by End User

7.3.5.3 UK

7.3.5.3.1 Market size and forecast, by Product

7.3.5.3.2 Market size and forecast, by Application

7.3.5.3.3 Market size and forecast, by End User

7.3.5.4 Rest of Europe

7.3.5.4.1 Market size and forecast, by Product

7.3.5.4.2 Market size and forecast, by Application

7.3.5.4.3 Market size and forecast, by End User

7.4 Asia-Pacific

7.4.1 Key trends and opportunities

7.4.2 Asia-Pacific Market size and forecast, by Product

7.4.3 Asia-Pacific Market size and forecast, by Application

7.4.4 Asia-Pacific Market size and forecast, by End User

7.4.5 Asia-Pacific Market size and forecast, by country

7.4.5.1 Japan

7.4.5.1.1 Market size and forecast, by Product

7.4.5.1.2 Market size and forecast, by Application

7.4.5.1.3 Market size and forecast, by End User

7.4.5.2 China

7.4.5.2.1 Market size and forecast, by Product

7.4.5.2.2 Market size and forecast, by Application

7.4.5.2.3 Market size and forecast, by End User

7.4.5.3 India

7.4.5.3.1 Market size and forecast, by Product

7.4.5.3.2 Market size and forecast, by Application

7.4.5.3.3 Market size and forecast, by End User

7.4.5.4 Australia

7.4.5.4.1 Market size and forecast, by Product

7.4.5.4.2 Market size and forecast, by Application

7.4.5.4.3 Market size and forecast, by End User

7.4.5.5 Rest of Asia-Pacific

7.4.5.5.1 Market size and forecast, by Product

7.4.5.5.2 Market size and forecast, by Application

7.4.5.5.3 Market size and forecast, by End User

7.5 LAMEA

7.5.1 Key trends and opportunities

7.5.2 LAMEA Market size and forecast, by Product

7.5.3 LAMEA Market size and forecast, by Application

7.5.4 LAMEA Market size and forecast, by End User

7.5.5 LAMEA Market size and forecast, by country

7.5.5.1 Brazil

7.5.5.1.1 Market size and forecast, by Product

7.5.5.1.2 Market size and forecast, by Application

7.5.5.1.3 Market size and forecast, by End User

7.5.5.2 Saudi Arabia

7.5.5.2.1 Market size and forecast, by Product

7.5.5.2.2 Market size and forecast, by Application

7.5.5.2.3 Market size and forecast, by End User

7.5.5.3 South Africa

7.5.5.3.1 Market size and forecast, by Product

7.5.5.3.2 Market size and forecast, by Application

7.5.5.3.3 Market size and forecast, by End User

7.5.5.4 Rest of LAMEA

7.5.5.4.1 Market size and forecast, by Product

7.5.5.4.2 Market size and forecast, by Application

7.5.5.4.3 Market size and forecast, by End User

8.1. Introduction

8.2. Top winning strategies

8.3. Product Mapping of Top 10 Player

8.4. Competitive Dashboard

8.5. Competitive Heatmap

8.6. Key developments

9.1 3d Biotek LLC

9.1.1 Company overview

9.1.2 Company snapshot

9.1.3 Operating business segments

9.1.4 Product portfolio

9.1.5 Business performance

9.1.6 Key strategic moves and developments

9.2 Advanced Biomatrix, Inc.

9.2.1 Company overview

9.2.2 Company snapshot

9.2.3 Operating business segments

9.2.4 Product portfolio

9.2.5 Business performance

9.2.6 Key strategic moves and developments

9.3 Avantor, Inc.

9.3.1 Company overview

9.3.2 Company snapshot

9.3.3 Operating business segments

9.3.4 Product portfolio

9.3.5 Business performance

9.3.6 Key strategic moves and developments

9.4 Becton, Dickinson And Company

9.4.1 Company overview

9.4.2 Company snapshot

9.4.3 Operating business segments

9.4.4 Product portfolio

9.4.5 Business performance

9.4.6 Key strategic moves and developments

9.5 Corning Incorporated

9.5.1 Company overview

9.5.2 Company snapshot

9.5.3 Operating business segments

9.5.4 Product portfolio

9.5.5 Business performance

9.5.6 Key strategic moves and developments

9.6 Insphero AG

9.6.1 Company overview

9.6.2 Company snapshot

9.6.3 Operating business segments

9.6.4 Product portfolio

9.6.5 Business performance

9.6.6 Key strategic moves and developments

9.7 Lonza Group LTD.

9.7.1 Company overview

9.7.2 Company snapshot

9.7.3 Operating business segments

9.7.4 Product portfolio

9.7.5 Business performance

9.7.6 Key strategic moves and developments

9.8 Merck & Co., Inc.

9.8.1 Company overview

9.8.2 Company snapshot

9.8.3 Operating business segments

9.8.4 Product portfolio

9.8.5 Business performance

9.8.6 Key strategic moves and developments

9.9 Synthecon, Incorporated

9.9.1 Company overview

9.9.2 Company snapshot

9.9.3 Operating business segments

9.9.4 Product portfolio

9.9.5 Business performance

9.9.6 Key strategic moves and developments

9.10 Thermo Fisher Scientific Inc.

9.10.1 Company overview

9.10.2 Company snapshot

9.10.3 Operating business segments

9.10.4 Product portfolio

9.10.5 Business performance

9.10.6 Key strategic moves and development

LIST OF TABLES

TABLE 1. GLOBAL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 2. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD BASED PLATFORMS, BY REGION, 2021-2031 ($MILLION)

TABLE 3. 3D CELL CULTURE MARKET FOR SCAFFOLD BASED PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 4. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MACRO-SCALE, 2021-2031 ($MILLION)

TABLE 5. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY MICRO-SCALE, 2021-2031 ($MILLION)

TABLE 6. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY NANO-SCALE, 2021-2031 ($MILLION)

TABLE 7. GLOBAL SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET, BY SOLID SCAFFOLDS, 2021-2031 ($MILLION)

TABLE 8. 3D CELL CULTURE MARKET SIZE, FOR SCAFFOLD FREE PLATFORMS, BY REGION, 2021-2031 ($MILLION)

TABLE 9. 3D CELL CULTURE MARKET FOR SCAFFOLD FREE PLATFORMS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 10. 3D CELL CULTURE MARKET SIZE, FOR GELS, BY REGION, 2021-2031 ($MILLION)

TABLE 11. 3D CELL CULTURE MARKET FOR GELS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 12. 3D CELL CULTURE MARKET SIZE, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)

TABLE 13. 3D CELL CULTURE MARKET FOR BIOREACTORS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 14. 3D CELL CULTURE MARKET SIZE, FOR MICROCHIPS, BY REGION, 2021-2031 ($MILLION)

TABLE 15. 3D CELL CULTURE MARKET FOR MICROCHIPS, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 16. 3D CELL CULTURE MARKET SIZE, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)

TABLE 17. 3D CELL CULTURE MARKET FOR SERVICES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 18. GLOBAL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 19. 3D CELL CULTURE MARKET SIZE, FOR CANCER RESEARCH, BY REGION, 2021-2031 ($MILLION)

TABLE 20. 3D CELL CULTURE MARKET FOR CANCER RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 21. 3D CELL CULTURE MARKET SIZE, FOR STEM CELL RESEARCH, BY REGION, 2021-2031 ($MILLION)

TABLE 22. 3D CELL CULTURE MARKET FOR STEM CELL RESEARCH, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 23. 3D CELL CULTURE MARKET SIZE, FOR DRUG DISCOVERY, BY REGION, 2021-2031 ($MILLION)

TABLE 24. 3D CELL CULTURE MARKET FOR DRUG DISCOVERY, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 25. 3D CELL CULTURE MARKET SIZE, FOR REGENERATIVE MEDICINE, BY REGION, 2021-2031 ($MILLION)

TABLE 26. 3D CELL CULTURE MARKET FOR REGENERATIVE MEDICINE, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 27. GLOBAL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 28. 3D CELL CULTURE MARKET SIZE, FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2021-2031 ($MILLION)

TABLE 29. 3D CELL CULTURE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 30. 3D CELL CULTURE MARKET SIZE, FOR CONTRACT RESEARCH LABORATORIES, BY REGION, 2021-2031 ($MILLION)

TABLE 31. 3D CELL CULTURE MARKET FOR CONTRACT RESEARCH LABORATORIES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 32. 3D CELL CULTURE MARKET SIZE, FOR ACADEMIC INSTITUTES, BY REGION, 2021-2031 ($MILLION)

TABLE 33. 3D CELL CULTURE MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 34. 3D CELL CULTURE MARKET, BY REGION, 2021-2031 ($MILLION)

TABLE 35. NORTH AMERICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 36. NORTH AMERICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 37. NORTH AMERICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 38. NORTH AMERICA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 39. U.S. 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 40. U.S. 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 41. U.S. 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 42. CANADA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 43. CANADA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 44. CANADA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 45. MEXICO 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 46. MEXICO 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 47. MEXICO 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 48. EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 49. EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 50. EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 51. EUROPE 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 52. GERMANY 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 53. GERMANY 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 54. GERMANY 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 55. FRANCE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 56. FRANCE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 57. FRANCE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 58. UK 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 59. UK 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 60. UK 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 61. REST OF EUROPE 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 62. REST OF EUROPE 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 63. REST OF EUROPE 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 64. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 65. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 66. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 67. ASIA-PACIFIC 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 68. JAPAN 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 69. JAPAN 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 70. JAPAN 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 71. CHINA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 72. CHINA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 73. CHINA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 74. INDIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 75. INDIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 76. INDIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 77. AUSTRALIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 78. AUSTRALIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 79. AUSTRALIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 80. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 81. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 82. REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 83. LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 84. LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 85. LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 86. LAMEA 3D CELL CULTURE MARKET, BY COUNTRY, 2021-2031 ($MILLION)

TABLE 87. BRAZIL 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 88. BRAZIL 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 89. BRAZIL 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 90. SAUDI ARABIA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 91. SAUDI ARABIA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 92. SAUDI ARABIA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 93. SOUTH AFRICA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 94. SOUTH AFRICA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 95. SOUTH AFRICA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 96. REST OF LAMEA 3D CELL CULTURE MARKET, BY PRODUCT, 2021-2031 ($MILLION)

TABLE 97. REST OF LAMEA 3D CELL CULTURE MARKET, BY APPLICATION, 2021-2031 ($MILLION)

TABLE 98. REST OF LAMEA 3D CELL CULTURE MARKET, BY END USER, 2021-2031 ($MILLION)

TABLE 99.3D BIOTEK LLC: COMPANY SNAPSHOT

TABLE 100.3D BIOTEK LLC: OPERATING SEGMENTS

TABLE 101.3D BIOTEK LLC: PRODUCT PORTFOLIO

TABLE 102.3D BIOTEK LLC: NET SALES,

TABLE 103.3D BIOTEK LLC: KEY STRATERGIES

TABLE 104.ADVANCED BIOMATRIX, INC.: COMPANY SNAPSHOT

TABLE 105.ADVANCED BIOMATRIX, INC.: OPERATING SEGMENTS

TABLE 106.ADVANCED BIOMATRIX, INC.: PRODUCT PORTFOLIO

TABLE 107.ADVANCED BIOMATRIX, INC.: NET SALES,

TABLE 108.ADVANCED BIOMATRIX, INC.: KEY STRATERGIES

TABLE 109.AVANTOR, INC.: COMPANY SNAPSHOT

TABLE 110.AVANTOR, INC.: OPERATING SEGMENTS

TABLE 111.AVANTOR, INC.: PRODUCT PORTFOLIO

TABLE 112.AVANTOR, INC.: NET SALES,

TABLE 113.AVANTOR, INC.: KEY STRATERGIES

TABLE 114.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT

TABLE 115.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS

TABLE 116.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO

TABLE 117.BECTON, DICKINSON AND COMPANY: NET SALES,

TABLE 118.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES

TABLE 119.CORNING INCORPORATED: COMPANY SNAPSHOT

TABLE 120.CORNING INCORPORATED: OPERATING SEGMENTS

TABLE 121.CORNING INCORPORATED: PRODUCT PORTFOLIO

TABLE 122.CORNING INCORPORATED: NET SALES,

TABLE 123.CORNING INCORPORATED: KEY STRATERGIES

TABLE 124.INSPHERO AG: COMPANY SNAPSHOT

TABLE 125.INSPHERO AG: OPERATING SEGMENTS

TABLE 126.INSPHERO AG: PRODUCT PORTFOLIO

TABLE 127.INSPHERO AG: NET SALES,

TABLE 128.INSPHERO AG: KEY STRATERGIES

TABLE 129.LONZA GROUP LTD.: COMPANY SNAPSHOT

TABLE 130.LONZA GROUP LTD.: OPERATING SEGMENTS

TABLE 131.LONZA GROUP LTD.: PRODUCT PORTFOLIO

TABLE 132.LONZA GROUP LTD.: NET SALES,

TABLE 133.LONZA GROUP LTD.: KEY STRATERGIES

TABLE 134.MERCK & CO., INC.: COMPANY SNAPSHOT

TABLE 135.MERCK & CO., INC.: OPERATING SEGMENTS

TABLE 136.MERCK & CO., INC.: PRODUCT PORTFOLIO

TABLE 137.MERCK & CO., INC.: NET SALES,

TABLE 138.MERCK & CO., INC.: KEY STRATERGIES

TABLE 139.SYNTHECON, INCORPORATED: COMPANY SNAPSHOT

TABLE 140.SYNTHECON, INCORPORATED: OPERATING SEGMENTS

TABLE 141.SYNTHECON, INCORPORATED: PRODUCT PORTFOLIO

TABLE 142.SYNTHECON, INCORPORATED: NET SALES,

TABLE 143.SYNTHECON, INCORPORATED: KEY STRATERGIES

TABLE 144.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

TABLE 145.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS

TABLE 146.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO

TABLE 147.THERMO FISHER SCIENTIFIC INC.: NET SALES,

TABLE 148.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES LIST OF FIGURES

FIGURE 1.3D CELL CULTURE MARKET SEGMENTATION

FIGURE 2.3D CELL CULTURE MARKET,2021-2031

FIGURE 3.3D CELL CULTURE MARKET,2021-2031

FIGURE 4. TOP INVESTMENT POCKETS, BY REGION

FIGURE 5.PORTER FIVE-1

FIGURE 6.PORTER FIVE-2

FIGURE 7.PORTER FIVE-3

FIGURE 8.PORTER FIVE-4

FIGURE 9.PORTER FIVE-5

FIGURE 10.TOP PLAYER POSITIONING

FIGURE 11.3D CELL CULTURE MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 12.3D CELL CULTURE MARKET,BY PRODUCT,2021(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD BASED PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SCAFFOLD FREE PLATFORMS 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF GELS 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BIOREACTORS 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF MICROCHIPS 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 18.COMPARATIVE SHARE ANALYSIS OF SERVICES 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 19.3D CELL CULTURE MARKET,BY APPLICATION,2021(%)

FIGURE 20.COMPARATIVE SHARE ANALYSIS OF CANCER RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 21.COMPARATIVE SHARE ANALYSIS OF STEM CELL RESEARCH 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 22.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 23.COMPARATIVE SHARE ANALYSIS OF REGENERATIVE MEDICINE 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 24.3D CELL CULTURE MARKET,BY END USER,2021(%)

FIGURE 25.COMPARATIVE SHARE ANALYSIS OF BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 26.COMPARATIVE SHARE ANALYSIS OF CONTRACT RESEARCH LABORATORIES 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ACADEMIC INSTITUTES 3D CELL CULTURE MARKET,2021-2031(%)

FIGURE 28.3D CELL CULTURE MARKET BY REGION,2021

FIGURE 29.U.S. 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 30.CANADA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 31.MEXICO 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 32.GERMANY 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 33.FRANCE 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 34.UK 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 35.REST OF EUROPE 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 36.JAPAN 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 37.CHINA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 38.INDIA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 39.AUSTRALIA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 40.REST OF ASIA-PACIFIC 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 41.BRAZIL 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 42.SAUDI ARABIA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 43.SOUTH AFRICA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 44.REST OF LAMEA 3D CELL CULTURE MARKET,2021-2031($MILLION)

FIGURE 45. TOP WINNING STRATEGIES, BY YEAR

FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 49.COMPETITIVE DASHBOARD

FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 51.3D BIOTEK LLC.: NET SALES ,($MILLION)

FIGURE 52.ADVANCED BIOMATRIX, INC..: NET SALES ,($MILLION)

FIGURE 53.AVANTOR, INC..: NET SALES ,($MILLION)

FIGURE 54.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)

FIGURE 55.CORNING INCORPORATED.: NET SALES ,($MILLION)

FIGURE 56.INSPHERO AG.: NET SALES ,($MILLION)

FIGURE 57.LONZA GROUP LTD..: NET SALES ,($MILLION)

FIGURE 58.MERCK & CO., INC..: NET SALES ,($MILLION)

FIGURE 59.SYNTHECON, INCORPORATED.: NET SALES ,($MILLION)

FIGURE 60.THERMO FISHER SCIENTIFIC INC..: NET SALES ,($MILLION